Dr. Epstein created novel drugs for the treating glaucoma, resulting in 10 patents that involve all areas of ophthalmic patient care and treatment. In 2012, he received Duke University College of Medication Medical Alumni Association's Distinguished Faculty Award. David Epstein was a giant in the field of glaucoma research, as well as being an inspiring mentor to young researchers and a very important head within ARVO, says Mark Petrash, PhD, Chair and FARVO of the ARVO Foundation.The June problem of JACR is an important source for radiology and nuclear medicine professionals as well as students seeking medical and educational improvement.
Kids at Growing Risk of Deadly ‘Superbug’ Infection: Research: – THURSDAY, Oct. 22, 2015 – – Rates of a deadly superbug infection are on the rise among American children, those aged 5 and young especially, a fresh study shows. The infections are caused by a type of bacterias called Carbapenem-resistant Enterobacteriaceae . CRE is many common in hospitals and long-term treatment centers and can be resistant to numerous types of antibiotics.